IBM and Mount Sinai Research Link Mitochondria to Effectiveness of Cancer Drug Treatments

Researchers from Mount Sinai and IBM say they have discovered a new clue in explaining how cancer cells with identical genomes can respond differently to the same therapy. The scientists showed the number of mitochondria in a cell is, in great part, associated with how the cancer responds to drug therapy.  Although cancer treatments continue to improve as technology progresses, researchers still struggle in explaining why and how cancer cells respond to treatments of oncological disease.  Cancer cells with matching genetic makeup will respond differently to the same treatment much of the time. By combining computational and biological methods and tools, they have uncovered a clue to this behavior.  TrialSite News provides a link to the actual study.